Rethinking Postpartum Glucose Assessment: Is One-Hour Testing the Key to Success? [0.03%]
重新思考产后血糖评估：一小时检测能否成功的关键？
Aoife M Egan,Fidelma P Dunne
Aoife M Egan
Liver Fibrosis Testing in Patients With Type 2 Diabetes: The Time Is Now [0.03%]
2型糖尿病患者的肝纤维化检测：时机已到
Mirko Zoncapè,Emmanuel A Tsochatzis
Mirko Zoncapè
Response to Comment on Wong et al. Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care 2025;48:292-300 [0.03%]
伍等人关于GLP-1受体激动剂对肥胖或超重患者体重减轻、BMI和腰围疗效的系统评价、meta分析和Meta回归的评论答复《糖尿病护理》2025年；48卷：292-300页
Hon Jen Wong,Bryan Sim,Yao Hao Teo et al.
Hon Jen Wong et al.
Comment on Wong et al. Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care 2025;48:292-300 [0.03%]
汪等。GLP-1受体激动剂对肥胖或超重患者体重减轻、BMI和腰围的有效性：对47项随机对照试验的系统评价、荟萃分析和荟萃回归分析评论。Diabetes Care 2025;48:292-300
Jian Huang
Jian Huang
Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies [0.03%]
钠葡萄糖共转运蛋白2抑制剂的使用与2型糖尿病患者肝相关事件风险的关系：观察性队列研究的荟萃分析
Alessandro Mantovani,Riccardo Morandin,Maria Giovanna Lando et al.
Alessandro Mantovani et al.
Background: There is uncertainty regarding effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the risk of major adverse liver-related outcomes (MALOs). ...
Cost-effectiveness of Semaglutide Compared With Other Glucose-Lowering Medications in Treating Type 2 Diabetes: A Comprehensive Systematic Review and Meta-analysis [0.03%]
与其它降糖药物相比，塞马鲁肽治疗2型糖尿病的性价比：全面系统评价和meta分析
Ziyun Liu,Baoqi Zeng,Feng Sun et al.
Ziyun Liu et al.
Background: Significant clinical efficacy has been shown for semaglutide in managing type 2 diabetes (T2D); however, its cost-effectiveness remains uncertain. ...
Comment on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242 [0.03%]
Maddaloni等人的评论： osteoprotegerin、osteopontin和osteocalcin与2型糖尿病患者心血管事件的相关性：EXSCEL研究的新见解《糖尿病护理》2025年；48：235-242
Kun Zhang
Kun Zhang
Effectiveness of Low Intensity Mental Health Support via a Telehealth Enabled Network (LISTEN) for Adults With Diabetes Distress: A Parallel Group, Pragmatic Randomized Controlled Trial [0.03%]
针对糖尿病患者的低强度心理支持的远程健康网络（LISTEN）有效性的实用随机对照试验：糖尿病困扰成人患者干预措施的效果分析
Edith E Holloway,Laura Jenkins,Paul A Agius et al.
Edith E Holloway et al.
Objective: To assess the effectiveness of Low Intensity mental health Support via a Telehealth Enabled Network (LISTEN), facilitated by diabetes health professionals, for reducing diabetes distress among adults with type ...
About the Editor: Amalia Gastaldelli, PhD-Mapping Physiological Mechanisms of Glucose and Lipid Metabolism [0.03%]
关于编辑：阿马利亚·加斯塔尔德利博士-绘制葡萄糖和脂质代谢生理机制图谱
Benjamin Page
Benjamin Page
Editorial
Diabetes care. 2025 Jun 1;48(6):862. DOI:10.2337/dci25-0046 2025
Benjamin Page
Benjamin Page
Editorial
Diabetes care. 2025 Jun 1;48(6):861. DOI:10.2337/dci25-0047 2025